Lowenstein Represents Longtime Client Indorama Ventures in Acquisition of KEMELIX and FLOWSOLVE

Lowenstein Sandler represented Indorama Ventures (BKK: IVL), a global leader in sustainable chemicals that has been a client of the firm's since 2003, in an agreement by its Indovinya business segment, through subsidiary Indorama Ventures Oxides LLC, to acquire two major brands in the energy extraction sector from Cargill Bioindustrial UK Limited: KEMELIX and FLOWSOLVE.

The acquisition is a strategic move to expand Indovinya's specialty surfactants offerings, particularly in demulsifiers and flow assurance products, supporting its growth trajectory in this market. It brings valuable assets to Indovinya's portfolio, including highly regarded trademarks, long-standing customer relationships, 25 patents, tolling rights, and an R&D facility based in Houston, Texas.

Central to the deal are the renowned KEMELIX and FLOWSOLVE brands, known for their advanced formulations and excellent performance in the oil and gas sector. KEMELIX, a flagship brand in the demulsification segment, offers high-performance demulsifiers that support efficient water separation from crude oil. FLOWSOLVE's advanced additives improve the flow of crude oil from the reservoir to the refinery, optimizing the entire extraction process.

Through this acquisition, Indorama Ventures strengthens its Indovinya segment, reinforces its commitment to innovation in the specialty surfactants market, and enhances its footprint in the energy sector while continuing to diversify its portfolio across multiple high-growth industries.

Lowenstein has represented Indorama since 2003, in such transactions as:

• Agreement to purchase the chemical unit of Oxiteno Ultrapar from Brazilian conglomerate Ultrapar Participações SA for $1.3 Billion
• Acquisition of CarbonLite's Texas PET recycling facility
• $2 Billion Acquisition of Huntsman's Chemicals Units
• Acquisition of M G Chemicals' Corpus Christi production facility
• Purchase of Alabama manufacturing facility from BP Amoco Chemical Company
• Acquisition of the PTA business of CEPSA
  
  

The Lowenstein deal team included Nicholas San Filippo IV, Mitchell McDonald, Amani Taha, Nicholas G. Mehler, Kristin V. Taylor, and Megan Monson.